Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04642365
Title A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN | BEL | AUS

Facility Status City State Zip Country Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Peter Maccallum Cancer Institute; Clinical Trial Unit Melbourne Victoria 3000 Australia Details
Cliniques Universitaires St-Luc Bruxelles 1200 Belgium Details
BC Cancer Agency - Vancouver Vancouver British Columbia V5Z 4E6 Canada Details
The Ottawa Hospital Cancer Centre Ottawa Ontario K2H 6C2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1Z5 Canada Details
Rigshospitalet; Onkologisk Klinik København Ø 2100 Denmark Details
Clinica Universitaria de Navarra Pamplona Navarra 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Fundacion Jimenez Diaz; Servicio de Oncologia Madrid 28040 Spain Details
Centro Integral Oncologico Clara Campal; Servicio de Oncología Madrid 28050 Spain Details
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field